Document Detail

[In Process Citation].
MedLine Citation:
PMID:  23535549     Owner:  NLM     Status:  In-Data-Review    
At the beginning of the 20th Century, cervical cancer was the leading cause of death from cancer in women. A marked decline in cervical cancer has been observed since the 1960s, in parallel with the introduction of the Papanicolau (Pap) test as a cytological screening method. Today, Pap smear screening is still the most widely used tool for cervical cancer prevention. Testing for human papillomavirus (HPV) in cervical specimens or a combination of Pap and HPV testing are also now available. In this article we compare current guidelines for cervical cancer screening in Switzerland with those in other European countries. In view of the opportunities offered by HPV testing and, since 2008, HPV vaccination, current guidelines for cervical cancer screening should be updated. Both the choice of screening tests and general organization of cervical cancer screening should be reviewed.
Sarah Untiet; Nicole Schmidt; Nicola Low; Patrick Petignat
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Therapeutische Umschau. Revue thérapeutique     Volume:  70     ISSN:  0040-5930     ISO Abbreviation:  Ther Umsch     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0407224     Medline TA:  Ther Umsch     Country:  Switzerland    
Other Details:
Languages:  ger     Pagination:  223-30     Citation Subset:  IM    
Hôpitaux Universitaires de Genève (HUG), Genf.
Vernacular Title:
Gebärmutterhalskrebs-Screening in der Schweiz - aktueller Stand und neue Herausforderungen.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  [In Process Citation].
Next Document:  [In Process Citation].